Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound - Takeaways - MDSpire

Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound

  • By

  • Christina Lenschow

  • Andreas Wennmann

  • Anne Hendricks

  • Christoph-Thomas Germer

  • Martin Fassnacht

  • Andreas Buck

  • Rudolf A. Werner

  • Lars Plassmeier

  • Nicolas Schlegel

  • August 9, 2022

  • 0 min

Share

  • 1

    Primary hyperparathyroidism (pHPT) is the third most common endocrine disorder, primarily treated through surgical removal of hyperfunctioning glands.

  • 2

    Preoperative imaging, including ultrasound and [99mTc]-sestamibi scintigraphy, is standard for locating abnormal parathyroid tissue before surgery.

  • 3

    Negative preoperative imaging correlates with reduced surgical success rates, highlighting the importance of accurate localization diagnostics.

  • 4

    Different imaging modalities vary in sensitivity, with ultrasound and radionuclide studies being more reliable than MRI for detecting parathyroid adenomas.

  • 5

    The study aims to improve preoperative localization diagnostics for pHPT by systematically re-evaluating existing diagnostic algorithms.

Original Source(s)

Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound

  • by Christina Lenschow, Andreas Wennmann, Anne Hendricks, Christoph-Thomas Germer, Martin Fassnacht, Andreas Buck, Rudolf A. Werner, Lars Plassmeier, Nicolas Schlegel

  • August 9, 2022

Related Content

Editorial: Advancing benign surgery: techniques, outcomes, and educational innovations

Comparative Analysis of Three Surgical Techniques for Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES)

Postoperative Step Counts Tied to Surgical Recovery

Wearable-measured mobility—but not heart rate variability or wellness scores—was associated with length of stay, complications, and readmissions